Scarica l'app Stockscreener
2.25
1.32%
-0.03
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché INBS Giù?
Forum
Previsione
Frazionamento azionario
Intelligent Bio Solutions Inc Borsa (INBS) Ultime notizie
INBSIntelligent Bio Solutions Inc Revenue Breakdown - Finviz
INBS Forecast — Price Target — Prediction for 2027 - TradingView
12Q Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Intelligent Bio Solutions Inc. – NASDAQ:INBS - TradingView
Enterprise value to EBIT forward of Intelligent Bio Solutions Inc. – NASDAQ:INBS - TradingView
Intelligent Bio Solutions Inc. Actuals & Estimates (NASDAQ:INBS) - TradingView
Intelligent Bio Solutions Inc (INBS) Valuation: PE, PB & Fair Value Analysis - TradingKey
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Intelligent Bio Solutions Inc (INBS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Intelligent Bio Solutions Inc (INBS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Intelligent Bio Solutions Inc (INBS) Institutional Confidence - TradingKey
Intelligent Bio Solutions Inc (INBS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Intelligent Bio Solutions Inc (INBS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Intelligent Bio Solutions Inc (INBS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Intelligent Bio Solutions Advances Codeine Drug Test Studies - TipRanks
Intelligent Bio Solutions launches interference study to support FDA 510(k) for codeine detection - TradingView
Interference study backs Intelligent Bio (NASDAQ: INBS) U.S. codeine test - Stock Titan
Intelligent Bio Solutions starts interference study for FDA submission By Investing.com - Investing.com South Africa
Intelligent Bio Solutions starts interference study for FDA submission - Investing.com
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry - TradingView
Intelligent Bio Solutions Initiates Interference Study to Support FDA 510(k) Submission for Drug Screening System - Quiver Quantitative
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry - The Globe and Mail
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Share Price, INBS Stock News, INBS Share Price & Updates - Kalkine
Intelligent Bio Solutions Inc. Financial Disclosures & SEC Filings - TradingView
INBS Q1 2025 Earnings: EPS Misses Estimates as Company Reports No RevenueProduct Revenue Analysis - newsline.com
INBS Q1 2025 Earnings: Earnings Miss Widens as Losses DeepenDividend Cut Risk - newsline.com
Intelligent Bio Solutions (INBS) Holds Near Support Amid Quiet Trading SessionMACD Signal Stocks - newsline.com
Intelligent Bio Solutions (INBS) Holds Steady Near Key Support After Modest PullbackGamma Exposure - newsline.com
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference Over June 16-18 - 富途牛牛
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 - marketscreener.com
Vegas microcap conference adds Intelligent Bio Solutions to lineup - Stock Titan
Intelligent Bio Solutions (INBS) Launches Study for Drug Screeni - GuruFocus
Intelligent Bio Solutions Launches Multi-Site Study for FDA 510(k) Clearance of Fingerprint Drug Screening System 1 - Minichart
Intelligent Bio Solutions Launches FDA Study for Codeine Test - TipRanks
Intelligent Bio Solutions starts FDA study for fingerprint drug test - Investing.com
Intelligent begins multi-site study to support FDA 510(k) for codeine screening - TradingView
Intelligent Bio Solutions (NASDAQ: INBS) launches multi-site 510(k) codeine drug screening study - Stock Titan
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission - The Manila Times
Fingerprint drug test put in workers' hands in new U.S. study - Stock Titan
Intelligent Bio Solutions (INBS) Edges Higher: Testing Key Resistance at $2.70Fundamental Weighted - newsline.com
INBS Q1 2025 Earnings: EPS Misses Estimates Significantly, Revenue Not Reported, Stock Rises 2.19%Earnings Weakness Phase - The Legal Advocate
Intelligent Bio Solutions (INBS) Climbs 4.4% as Shares Test Key Resistance Near $2.71Delta Hedging - newsline.com
INBS Q1 2025 Earnings: Wider-Than-Expected Loss as Revenue Remains AbsentShort-Term Outlook - newsline.com
Intelligent Bio Solutions (INBS) Surges 7% as Shares Rebound from Support LevelIntraday Trade Ideas - The Legal Advocate
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider Loss Than Expected Weighs on SharesInstitutional Grade Picks - Newser
Intelligent Bio Solutions Inc. (INBS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider-Than-Expected Loss Amid Continued Pre-Revenue StageTrending Entry Points - Newser
INBS|Intelligent Bio Solutions Inc|Price:2.530|Chg%:-0.10 - TradingKey
Intelligent Bio Solutions Company Profile & Introduction - Moomoo
Intelligent Bio Solutions 3Q Loss $2.87M >INBS - Moomoo
[SCHEDULE 13G] INTELLIGENT BIO SOLUTIONS INC. Passive Investment Disclosure (>5%) - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Is Intelligent Bio Solutions (INBS) Undervalued After Q3 FY2026 - GuruFocus
Intelligent Bio Solutions (NASDAQ: INBS) grows Q3 revenue 46% with margins above 50% - Stock Titan
0.32%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):